Press kits

This information is intended for healthcare journalists, analysts and investors.

Pharmaceutical resources

ANORO™ ELLIPTA™

Arnuity™ Ellipta® & Incruse® Ellipta®

BLENREP (belantamab mafodotin-blmf)

BREO® ELLIPTA™

Dostarlimab

NUCALA® (mepolizumab)

The IMPACT study: InforMing the PAthway of COPD Treatment

Trelegy Ellipta

ZEJULA (niraparib)

Press release

April 29, 2020
Press release

Infographics

About Ovarian CancerPDF - 194.8KB PARP Inhibitor Mechanism of ActionPDF - 187.7KB PRIMA Trial BackgrounderPDF - 653.6KB Back to top

Vaccine resources

General resources

Partnership to Help Communities Protect and Care for Children Impacted by Disasters